Literature DB >> 11916347

The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants.

J Manjer1, S Carlsson, S Elmståhl, B Gullberg, L Janzon, M Lindström, I Mattisson, G Berglund.   

Abstract

In order to investigate potential selection bias in population-based cohort studies, participants (n = 28098) and non-participants (n = 40807) in the Malmö Diet and Cancer Study (MDCS) were compared with regard to cancer incidence and mortality. MDCS participants were also compared with participants in a mailed health survey with regard to subjective health, socio-demographic characteristics and lifestyle. Cancer incidence prior to recruitment was lower in non-participants, Cox proportional hazards analysis yielded a relative risk (RR) with a 95% confidence interval of 0.95 (0.90-1.00), compared with participants. During recruitment, cancer incidence was higher in non-participants, RR: 1.08 (1.01-1.17). Mortality was higher in non-participants both during, 3.55 (3.13-4.03), and following the recruitment period, 2.21 (2.03-2.41). The proportion reporting good health was higher in the MDCS than in the mailed health survey (where 74.6% participated), but the socio-demographic structure was similar. We conclude that mortality is higher in non-participants than in participants during recruitment and follow-up. It is also suggested that non-participants may have a lower cancer incidence prior to recruitment but a higher incidence during the recruitment period.

Entities:  

Mesh:

Year:  2001        PMID: 11916347     DOI: 10.1097/00008469-200112000-00003

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  187 in total

1.  Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies.

Authors:  Jenny Hansson; Maria Rosaria Galanti; Maria-Pia Hergens; Peeter Fredlund; Anders Ahlbom; Lars Alfredsson; Rino Bellocco; Marie Eriksson; Johan Hallqvist; Bo Hedblad; Jan-Håkan Jansson; Peter Nilsson; Nancy Pedersen; Ylva Trolle Lagerros; Per-Olof Ostergren; Cecilia Magnusson
Journal:  Eur J Epidemiol       Date:  2012-06-22       Impact factor: 8.082

2.  A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

Authors:  David Ulmert; Reza Kaboteh; Josef J Fox; Caroline Savage; Michael J Evans; Hans Lilja; Per-Anders Abrahamsson; Thomas Björk; Axel Gerdtsson; Anders Bjartell; Peter Gjertsson; Peter Höglund; Milan Lomsky; Mattias Ohlsson; Jens Richter; May Sadik; Michael J Morris; Howard I Scher; Karl Sjöstrand; Alice Yu; Madis Suurküla; Lars Edenbrandt; Steven M Larson
Journal:  Eur Urol       Date:  2012-01-27       Impact factor: 20.096

3.  Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women.

Authors:  Jonas Manjer; Robert Johansson; Per Lenner
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Anemia in the general population: prevalence, clinical correlates and prognostic impact.

Authors:  Andreas Martinsson; Charlotte Andersson; Pontus Andell; Sasha Koul; Gunnar Engström; J Gustav Smith
Journal:  Eur J Epidemiol       Date:  2014-06-21       Impact factor: 8.082

5.  The prediction of colorectal cancer using anthropometric measures: A Swedish population-based cohort study with 22 years of follow-up.

Authors:  Anna Andreasson; Hannes Hagström; Filip Sköldberg; Kristina Önnerhag; Axel C Carlsson; Peter T Schmidt; Anna M Forsberg
Journal:  United European Gastroenterol J       Date:  2019-05-24       Impact factor: 4.623

6.  Neighbourhood social participation and women's use of anxiolytic-hypnotic drugs: a multilevel analysis.

Authors:  K Johnell; J Merlo; J Lynch; G Blennow
Journal:  J Epidemiol Community Health       Date:  2004-01       Impact factor: 3.710

7.  A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemia.

Authors:  Xu Chen; Stefan Gustafsson; Thomas Whitington; Yan Borné; Erik Lorentzen; Jitong Sun; Peter Almgren; Jun Su; Robert Karlsson; Jie Song; Yi Lu; Yiqiang Zhan; Sara Hägg; Per Svensson; Karin E Smedby; Susan L Slager; Erik Ingelsson; Cecilia M Lindgren; Andrew P Morris; Olle Melander; Thomas Karlsson; Ulf de Faire; Kenneth Caidahl; Gunnar Engström; Lars Lind; Mikael C I Karlsson; Nancy L Pedersen; Johan Frostegård; Patrik K E Magnusson
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

8.  Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.

Authors:  Weiqiang Li; Mridu Middha; Mesude Bicak; Daniel D Sjoberg; Emily Vertosick; Anders Dahlin; Christel Häggström; Göran Hallmans; Ann-Charlotte Rönn; Pär Stattin; Olle Melander; David Ulmert; Hans Lilja; Robert J Klein
Journal:  Eur Urol       Date:  2018-07-07       Impact factor: 20.096

9.  Mortality among participants and non-participants in a prospective cohort study.

Authors:  Signe Benzon Larsen; Susanne Oksbjerg Dalton; Joachim Schüz; Jane Christensen; Kim Overvad; Anne Tjønneland; Christoffer Johansen; Anja Olsen
Journal:  Eur J Epidemiol       Date:  2012-10-16       Impact factor: 8.082

10.  Five meal patterns are differently associated with nutrient intakes, lifestyle factors and energy misreporting in a sub-sample of the Malmö Diet and Cancer cohort.

Authors:  Isabel Holmbäck; Ulrika Ericson; Bo Gullberg; Elisabet Wirfält
Journal:  Food Nutr Res       Date:  2009-09-09       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.